Rohto Pharmaceutical Co.,Ltd. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €2.25B +6.3% €223.68M +5.4% 9.9% -0.00090 pp €225.95M +5.6% 10.0% -0.00070 pp
    (estimated) €2.12B +1.7% €212.29M +9.0% 10.0% +0.0067 pp €214.00M +13.7% 10.1% +0.011 pp
    (estimated) €2.08B +4.1% €194.72M +5.5% 9.4% +0.0012 pp €188.19M +18.9% 9.0% +0.011 pp
    (estimated) €2.00B +4.1% €184.59M +1.1% 9.2% -0.0027 pp €158.31M -10.0% 7.9% -0.012 pp
    (estimated) €1.92B +9.3% €182.53M +3.4% 9.5% -0.0054 pp €175.86M -32.8% 9.2% -0.057 pp
    €1.76B +14.0% €176.47M +0.2% 10.0% -0.014 pp €261.79M +6.6% 14.9% -0.010 pp
    €1.54B +13.5% €176.07M +17.3% 11.4% +0.0037 pp €245.63M +5.7% 15.9% -0.012 pp
    €1.36B +19.5% €150.13M +24.8% 11.1% +0.0047 pp €232.40M +5.8% 17.1% -0.022 pp
    €1.14B +10.3% €120.24M +26.2% 10.6% +0.013 pp €219.57M +27.3% 19.3% +0.026 pp
    €1.03B -3.9% €95.29M +8.7% 9.2% +0.011 pp €172.52M +19.0% 16.7% +0.032 pp
    €1.07B +2.6% €87.71M +57.3% 8.2% +0.028 pp €144.98M -11.1% 13.5% -0.021 pp
    €1.05B +6.9% €55.77M +5.5% 5.3% -0.00072 pp €163.13M +16.5% 15.6% +0.013 pp
    €977.77M +11.1% €52.87M -7.2% 5.4% -0.011 pp €140.05M +41.3% 14.3% +0.031 pp
    €879.90M -7.1% €56.98M +10.0% 6.5% +0.010 pp €99.08M +8.4% 11.3% +0.016 pp
    €947.51M +9.5% €51.78M +5.4% 5.5% -0.0021 pp €91.38M +4.0% 9.6% -0.0051 pp
    €865.08M +5.5% €49.12M -3.5% 5.7% -0.0053 pp €87.87M -39.1% 10.2% -0.075 pp
    €820.05M +12.0% €50.92M +10.6% 6.2% -0.00076 pp €144.39M +14.8% 17.6% +0.0043 pp
    €732.31M +6.8% €46.03M -1.2% 6.3% -0.0051 pp €125.81M +15.9% 17.2% +0.013 pp
    €685.39M +4.5% €46.58M +2.7% 6.8% -0.0012 pp €108.55M -12.1% 15.8% -0.030 pp
    €656.02M +1.6% €45.34M +2.5% 6.9% +0.00063 pp €123.55M +9.0% 18.8% +0.013 pp
    €645.59M +2.6% €44.21M +26.5% 6.8% +0.013 pp €113.31M +44.9% 17.6% +0.051 pp
    €629.49M +2.2% €34.94M -18.4% 5.6% -0.014 pp €78.18M -16.0% 12.4% -0.027 pp
    €615.86M €42.83M 7.0% €93.07M 15.1%

    Notifications